MedPath

PMS-NAPROXEN

PMS-NAPROXEN

Dormant
DIN Number

02017237

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02017237
AIG Number0109634003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AE02 NAPROXEN
Product Specifications
Dosage FormSuppository
Route of AdministrationRectal
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

NAPROXENActive
Strength: 500 MG
Monograph: NAPROXEN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.